Crossmark

BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding

Crossref DOI link: https://doi.org/10.1186/s13052-025-02042-3

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perretta, Rosa

Torca, Juan José Borraz

De Luca, Giuseppina

Donà, Marta

Gasparella, Martina

Rizzato, Elisa

Partigiani, Nicola Bertazza https://orcid.org/0009-0007-6113-9312
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 1 April 2025

Accepted: 31 May 2025

First Online: 1 July 2025

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hospital of Vicenza. Written informed consent was obtained from all participants or their legal guardians. The ethics approval code is 05/22 B, date of approval 11 January 2022.

: Consent for publication of study findings was obtained from all participants or their legal guardians at the time of enrollment.

: The authors have no conflict of interest to declare.

: The authors report no disclosures.

Document is current

Any future updates will be listed below